Novartis sues AZ’s Alexion over ‘false and misleading’ Ultomiris marketing

22nd October 2025 Uncategorised 0

Novartis has filed suit against AstraZeneca’s rare disease unit, claiming that certain marketing materials for Alexion’s Ultomiris create an inaccurate impression of Novartis’ rival drug Fabhalta.

More: Novartis sues AZ’s Alexion over ‘false and misleading’ Ultomiris marketing
Source: fierce